ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

Go back to ClearOne to acquire Cortigent in merger deal, plans $10M-$15M raise

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical

July 2, 2026 8:00 AM EDT

SALT LAKE CITY--(BUSINESS WIRE)-- ClearOne, Inc. (Nasdaq: CLRO) (ClearOne) announced today that it has entered into a definitive agreement and plan of merger (the Agreement) among its wholly-owned subsidiary (MergerSub), Vivani Medical, Inc. (Nasdaq: VANI; Vivani), and Cortigent, Inc. (Cortigent), a wholly-owned subsidiary of Vivani, pursuant to which Cortigent will become a wholly-owned subsidiary of ClearOne (the Transaction) upon consummation.

In connection with the Transaction, ClearOne has agreed to file a registration statement on Form S-1 to raise a minimum of $10,000,000 and a maximum of $15,000,000 (the Financing) concurrently with... More